PUTNAM INVESTMENTS LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3,321,304
-37.9%
1,778,000
-44.6%
0.01%
-40.0%
Q3 2022$5,345,000
+755.2%
3,207,000
+542.7%
0.01%
+900.0%
Q2 2022$625,000
-17.0%
499,000
-13.1%
0.00%0.0%
Q1 2022$753,000
-10.5%
574,0000.0%0.00%0.0%
Q4 2021$841,000
-0.9%
574,0000.0%0.00%0.0%
Q3 2021$849,000
+12.2%
574,0000.0%0.00%0.0%
Q2 2021$757,000
+22.5%
574,000
+21.4%
0.00%0.0%
Q1 2021$618,000
-92.5%
473,000
-85.9%
0.00%
-93.3%
Q4 2020$8,209,000
+37.7%
3,348,000
+16.5%
0.02%
+25.0%
Q3 2020$5,961,000
-9.7%
2,875,0000.0%0.01%
-14.3%
Q2 2020$6,598,000
+24.4%
2,875,000
-17.7%
0.01%0.0%
Q1 2020$5,302,000
-8.0%
3,493,000
+17.8%
0.01%
+16.7%
Q4 2019$5,765,000
+93.7%
2,964,000
+31.6%
0.01%
+71.4%
Q3 2019$2,977,000
+15.3%
2,253,000
+94.2%
0.01%
+16.7%
Q2 2019$2,582,000
-2.5%
1,160,000
-20.9%
0.01%0.0%
Q1 2019$2,647,0001,467,0000.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 53,865,000$101,127,2803.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$165,397,6133.42%
Boussard & Gavaudan Investment Management LLP 11,898$21,871,5382.42%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$71,834,2261.71%
WOLVERINE ASSET MANAGEMENT LLC 79,876,000$149,367,3841.55%
CSS LLC/IL 4,747,000$8,868,6060.50%
Opti Capital Management, LP 3,000,000$5,611,9380.48%
Verition Fund Management LLC 16,459,000$30,786,5600.48%
Aequim Alternative Investments LP 5,000,000$9,352,5000.25%
MIZUHO SECURITIES USA LLC 1,097,000$2,047,6160.19%
View complete list of SAREPTA THERAPEUTICS INC shareholders